Challenges in Advanced Lung Cancer Diagnosis During the COVID-19 Pandemic

Chunhua Xu; Li Li; Wei Wang

doi:10.1177/15330338211050764

Challenges in Advanced Lung Cancer Diagnosis During the COVID-19 Pandemic

Technol Cancer Res Treat. 2021 Jan-Dec:20:15330338211050764. doi: 10.1177/15330338211050764.

Authors

Chunhua Xu^{1

2

3}, Li Li^{1

2

3}, Wei Wang^{1

2

3}

Affiliations

¹ 206608Nanjing Chest Hospital, Nanjing, China.
² Affiliated Nanjing Brain Hospital, 56647Nanjing Medical University, Nanjing, China.
³ Clinical Center of Nanjing Respiratory Diseases and Imaging, Nanjing, China.

Abstract

A pandemic of coronavirus diseases 2019 (COVID-19) outbreak is a major public health emergency that has spread in the fastest speed, and caused the most extensive infection world widely. Transbronchial biopsy (TBB) and computed tomography guided percutaneous needle biopsy (CTPNB) is the most common and significant method for the diagnosis of lung cancer. During the COVID-19 pandemic, the indications of TBB and CTPNB must be managed strictly. Therefore, it is extremely indispensable to perform meticulous and individualized management for lung cancer patients to protect the patients from COVID-19.

Keywords: Coronavirus disease 2019 (COVID-19); diagnosis; lung cancer; percutaneous needle biopsy; transbronchial biopsy.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Biopsy
Bronchi / pathology
Bronchoscopy / methods
COVID-19 / complications
COVID-19 / diagnosis
COVID-19 / epidemiology*
Diagnosis, Differential
Disease Susceptibility
Humans
Image-Guided Biopsy / methods
Lung / pathology
Lung Neoplasms / complications
Lung Neoplasms / diagnosis*
Medical Oncology / methods
Postoperative Period
Prognosis
SARS-CoV-2
Telemedicine
Tomography, X-Ray Computed